A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection

Descripción del Articulo

El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.
Detalles Bibliográficos
Autores: Allan-Blitz, Lao-Tzu, Hemarajata, Peera, Humphries, Romney M., Wynn, Adriane, Segura, Eddy R., Klausner, Jeffrey D.
Formato: artículo
Fecha de Publicación:2018
Institución:Universidad Peruana de Ciencias Aplicadas
Repositorio:UPC-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorioacademico.upc.edu.pe:10757/622635
Enlace del recurso:https://doi.org/10.1097/OLQ.0000000000000698
http://hdl.handle.net/10757/622635
Nivel de acceso:acceso abierto
Materia:Azithromycin
Ceftriaxone
Ciprofloxacin
DNA topoisomerase (ATP hydrolysing) A
Antibiotic resistance
Antibiotic sensitivity
Chlamydiasis
Cost benefit analysis
id UUPC_7e02df38e530b213ebd0127d3c51f2b9
oai_identifier_str oai:repositorioacademico.upc.edu.pe:10757/622635
network_acronym_str UUPC
network_name_str UPC-Institucional
repository_id_str 2670
dc.title.es.fl_str_mv A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection
title A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection
spellingShingle A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection
Allan-Blitz, Lao-Tzu
Azithromycin
Ceftriaxone
Ciprofloxacin
DNA topoisomerase (ATP hydrolysing) A
Antibiotic resistance
Antibiotic sensitivity
Chlamydiasis
Cost benefit analysis
title_short A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection
title_full A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection
title_fullStr A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection
title_full_unstemmed A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection
title_sort A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection
author Allan-Blitz, Lao-Tzu
author_facet Allan-Blitz, Lao-Tzu
Hemarajata, Peera
Humphries, Romney M.
Wynn, Adriane
Segura, Eddy R.
Klausner, Jeffrey D.
author_role author
author2 Hemarajata, Peera
Humphries, Romney M.
Wynn, Adriane
Segura, Eddy R.
Klausner, Jeffrey D.
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Allan-Blitz, Lao-Tzu
Hemarajata, Peera
Humphries, Romney M.
Wynn, Adriane
Segura, Eddy R.
Klausner, Jeffrey D.
dc.subject.es.fl_str_mv Azithromycin
Ceftriaxone
Ciprofloxacin
DNA topoisomerase (ATP hydrolysing) A
Antibiotic resistance
Antibiotic sensitivity
Chlamydiasis
Cost benefit analysis
topic Azithromycin
Ceftriaxone
Ciprofloxacin
DNA topoisomerase (ATP hydrolysing) A
Antibiotic resistance
Antibiotic sensitivity
Chlamydiasis
Cost benefit analysis
description El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.
publishDate 2018
dc.date.accessioned.none.fl_str_mv 2018-02-12T14:44:00Z
dc.date.available.none.fl_str_mv 2018-02-12T14:44:00Z
dc.date.issued.fl_str_mv 2018-02
dc.type.es.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a1584
format article
dc.identifier.citation.es.fl_str_mv A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection 2018, 45 (2):87 Sexually Transmitted Diseases
dc.identifier.issn.none.fl_str_mv 0148-5717
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1097/OLQ.0000000000000698
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10757/622635
dc.identifier.journal.es.fl_str_mv Sexually Transmitted Diseases
identifier_str_mv A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection 2018, 45 (2):87 Sexually Transmitted Diseases
0148-5717
Sexually Transmitted Diseases
url https://doi.org/10.1097/OLQ.0000000000000698
http://hdl.handle.net/10757/622635
dc.language.iso.es.fl_str_mv eng
language eng
dc.relation.url.es.fl_str_mv http://Insights.ovid.com/crossref?an=00007435-201802000-00004
dc.rights.es.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.es.fl_str_mv application/pdf
dc.publisher.es.fl_str_mv Lippincott Williams and Wilkins
dc.source.none.fl_str_mv reponame:UPC-Institucional
instname:Universidad Peruana de Ciencias Aplicadas
instacron:UPC
instname_str Universidad Peruana de Ciencias Aplicadas
instacron_str UPC
institution UPC
reponame_str UPC-Institucional
collection UPC-Institucional
bitstream.url.fl_str_mv https://repositorioacademico.upc.edu.pe/bitstream/10757/622635/1/license.txt
https://repositorioacademico.upc.edu.pe/bitstream/10757/622635/2/10.1097%20OLQ.0000000000000698.pdf
https://repositorioacademico.upc.edu.pe/bitstream/10757/622635/3/10.1097%20OLQ.0000000000000698.pdf.txt
https://repositorioacademico.upc.edu.pe/bitstream/10757/622635/4/10.1097%20OLQ.0000000000000698.pdf.jpg
bitstream.checksum.fl_str_mv 248222b1f11c2ad8cb204366338ffb12
344929522c1ac85c4db58950549fa369
206d4a494f25b973e051d7411c546a5a
a363e5ce723ee60446da78d01f796ffe
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Académico UPC
repository.mail.fl_str_mv upc@openrepository.com
_version_ 1863822620743434240
spelling 7f44090d9826b2621073e03a06005ad85003eb75b8e132d7f52827469d683b8f3a55003f26bea0b295a3098d9d4f2b539bf26f500ceff9eeddb1ed3b1a73a5a6247d2dfaf50097b6f91e6f243a7dbda33e2287b3d17150061f65556582520db115c259dadc4f7d3500Allan-Blitz, Lao-TzuHemarajata, PeeraHumphries, Romney M.Wynn, AdrianeSegura, Eddy R.Klausner, Jeffrey D.2018-02-12T14:44:00Z2018-02-12T14:44:00Z2018-02A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection 2018, 45 (2):87 Sexually Transmitted Diseases0148-5717https://doi.org/10.1097/OLQ.0000000000000698http://hdl.handle.net/10757/622635Sexually Transmitted DiseasesEl texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.From the *Division of Infectious Diseases, Department of Medicine, †Department of Laboratory Medicine, David Geffen School of Medicine, Department of Medicine, ‡Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA; §Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas, Lima, Peru; and ¶Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, CA Conflict of Interest and Sources of Funding: None declared. This research was supported by the United States National Institutes of Health grants R21AI117256 and R21AI109005 as well as the South American Program in HIV Prevention Research NIH/NIMH R25MH087222. Correspondence: Lao-Tzu Allan-Blitz, MD Candidate, 2018, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095. E‐mail: lallanblitz@mednet.ucla.edu. Received for publication February 21, 2017, and accepted July 30, 2017. DOI: 10.1097/OLQ.0000000000000698From the *Division of Infectious Diseases, Department of Medicine, †Department of Laboratory Medicine, David Geffen School of Medicine, Department of Medicine, ‡Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA; §Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas, Lima, Peru; and ¶Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, CA Conflict of Interest and Sources of Funding: None declared. This research was supported by the United States National Institutes of Health grants R21AI117256 and R21AI109005 as well as the South American Program in HIV Prevention Research NIH/NIMH R25MH087222. Correspondence: Lao-Tzu Allan-Blitz, MD Candidate, 2018, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095Revisión por paresapplication/pdfengLippincott Williams and Wilkinshttp://Insights.ovid.com/crossref?an=00007435-201802000-00004info:eu-repo/semantics/openAccessAzithromycinCeftriaxoneCiprofloxacinDNA topoisomerase (ATP hydrolysing) AAntibiotic resistanceAntibiotic sensitivityChlamydiasisCost benefit analysisA cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infectioninfo:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a1584reponame:UPC-Institucionalinstname:Universidad Peruana de Ciencias Aplicadasinstacron:UPC2018-06-15T22:11:39ZFrom the *Division of Infectious Diseases, Department of Medicine, †Department of Laboratory Medicine, David Geffen School of Medicine, Department of Medicine, ‡Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA; §Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas, Lima, Peru; and ¶Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, CA Conflict of Interest and Sources of Funding: None declared. This research was supported by the United States National Institutes of Health grants R21AI117256 and R21AI109005 as well as the South American Program in HIV Prevention Research NIH/NIMH R25MH087222. Correspondence: Lao-Tzu Allan-Blitz, MD Candidate, 2018, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095. E‐mail: lallanblitz@mednet.ucla.edu. Received for publication February 21, 2017, and accepted July 30, 2017. DOI: 10.1097/OLQ.0000000000000698LICENSElicense.txtlicense.txttext/plain; charset=utf-81745https://repositorioacademico.upc.edu.pe/bitstream/10757/622635/1/license.txt248222b1f11c2ad8cb204366338ffb12MD51falseORIGINAL10.1097 OLQ.0000000000000698.pdf10.1097 OLQ.0000000000000698.pdfapplication/pdf300622https://repositorioacademico.upc.edu.pe/bitstream/10757/622635/2/10.1097%20OLQ.0000000000000698.pdf344929522c1ac85c4db58950549fa369MD52trueTEXT10.1097 OLQ.0000000000000698.pdf.txt10.1097 OLQ.0000000000000698.pdf.txtExtracted Texttext/plain4784https://repositorioacademico.upc.edu.pe/bitstream/10757/622635/3/10.1097%20OLQ.0000000000000698.pdf.txt206d4a494f25b973e051d7411c546a5aMD53falseTHUMBNAIL10.1097 OLQ.0000000000000698.pdf.jpg10.1097 OLQ.0000000000000698.pdf.jpgGenerated Thumbnailimage/jpeg75072https://repositorioacademico.upc.edu.pe/bitstream/10757/622635/4/10.1097%20OLQ.0000000000000698.pdf.jpga363e5ce723ee60446da78d01f796ffeMD54false10757/622635oai:repositorioacademico.upc.edu.pe:10757/6226352026-02-17 17:46:22.975Repositorio Académico UPCupc@openrepository.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
score 13.940228
A cost analysis of gyrase a testing and targeted ciprofloxacin therapy Versus recommended 2-Drug therapy for neisseria gonorrhoeae Infection
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares